What is Vim?
Vim operates a sophisticated healthcare technology platform designed to harmonize incentives between healthcare payers and providers. By aligning these stakeholders, Vim empowers value-based care decisions, moving away from traditional fee-for-service models. Based in San Francisco, California, the company's innovative approach addresses critical challenges in healthcare delivery and financial alignment.
How much funding has Vim raised?
Vim has raised a total of $60M across 1 funding round:
Series B
$60M
Series B (2021): $60M with participation from Anthem Blue Cross and Blue Shield, Walgreens, Sequoia Capital, Optum Ventures, Frist Cressey Ventures, Great Point Ventures, and Premera Blue Cross
Key Investors in Vim
Anthem Blue Cross and Blue Shield
Anthem Blue Cross and Blue Shield is a major health insurance provider focused on delivering health, care, and coverage solutions to its members.
Walgreens
Walgreens is a leading American retail pharmacy and healthcare company, offering a wide range of health and wellness products and services through its extensive network of stores and digital platforms.
Sequoia Capital
Sequoia Capital is a globally recognized venture capital firm known for investing in early-stage and growth-stage technology companies, with a history of backing market leaders.
What's next for Vim?
The substantial enterprise-level backing and recent strategic investment signal a period of significant scaling and market expansion for Vim. This financing is poised to fuel further development of its technology, enhance its market penetration, and solidify its position as a leader in value-based care solutions. Vim is strategically positioned to drive transformative change in how healthcare is financed and delivered, focusing on improved patient outcomes and cost efficiencies.
See full Vim company page
